5300-00-5

Basic information

• Product Name: (2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoic acid methyl ester
• Synonyms: (2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoic acid methyl ester
• CAS NO: 5300-00-5
• Molecular Weight: 248.365
• Mol File: 5300-00-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoic acid methyl ester(5300-00-5)
• EPA Substance Registry System: (2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoic acid methyl ester(5300-00-5)

Safety Data

• Hazardous Substances Data: 5300-00-5(Hazardous Substances Data)

Upstream product

• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 79-77-6 (E)-β-ionone 
• 124-41-4 sodium methylate 

Downstream Products

• 66855-42-3 All-trans-N-retinyliden-n-butylamin 
• 66855-40-1 n-Butyl Retro-γ-setinoate 
• 66901-09-5 9-cis-retro-γ-retinal 
• 66901-08-4 11-cis-retro-γ-retinal 
• 66855-41-2 Retro γ retinal 
• 212118-26-8 3-Methoxy-4-[(2E,4E)-3-methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoylamino]-benzoic acid 2-trimethylsilanyl-ethyl ester 
• 212118-27-9 4-{Methyl-[(2E,4E)-3-methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoyl]-amino}-benzoic acid 2-trimethylsilanyl-ethyl ester 
• 212118-25-7 4-[(2E,4E)-3-Methyl-5-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2,4-dienoylamino]-benzoic acid 2-trimethylsilanyl-ethyl ester 
• 108898-22-2 3-methyl-5t-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2t,4-dienoyl chloride 
• 14398-42-6 (2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-enyl)penta-2,4-dienoic acid 
• 66855-38-7 Methyl Retro-γ-ionylideneacetate 
• 66855-39-8 Methyl Retro-γ-ionylideneacetate 

Relevant articles and documents

Synthesis and structure-activity relationships of 2- pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

The structure-activity relationships of two series of novel retinoids (2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates) have been investigated by evaluating their ability to induce differentiation in both human promyelocytic leukemia (H